These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38286355)

  • 1. Banff 2022 Vascularized Composite Allotransplantation Meeting Report: Diagnostic criteria for vascular changes.
    Cendales LC; Farris AB; Rosales I; Elder D; Gamboa-Dominguez A; Gelb B; Issa F; Ravindra K; Nankivell BJ; Talbot S; Xu XG; Moris D; Drachenberg CB; Kanitakis J; Selim MA
    Am J Transplant; 2024 May; 24(5):716-723. PubMed ID: 38286355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascularized composite allotransplantation: a closer look at the banff working classification.
    Schneider M; Cardones AR; Selim MA; Cendales LC
    Transpl Int; 2016 Jun; 29(6):663-71. PubMed ID: 26841362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing skin rejection in vascularized composite allotransplantation: advances and challenges.
    Sarhane KA; Khalifian S; Ibrahim Z; Cooney DS; Hautz T; Lee WP; Schneeberger S; Brandacher G
    Clin Transplant; 2014 Mar; 28(3):277-85. PubMed ID: 24476538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation.
    Kaufman CL; Kanitakis J; Weissenbacher A; Brandacher G; Mehra MR; Amer H; Zelger BG; Zelger B; Pomahac B; McDiarmid S; Cendales L; Morelon E
    SAGE Open Med; 2020; 8():2050312120940421. PubMed ID: 32704373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Banff 2007 working classification of skin-containing composite tissue allograft pathology.
    Cendales LC; Kanitakis J; Schneeberger S; Burns C; Ruiz P; Landin L; Remmelink M; Hewitt CW; Landgren T; Lyons B; Drachenberg CB; Solez K; Kirk AD; Kleiner DE; Racusen L
    Am J Transplant; 2008 Jul; 8(7):1396-400. PubMed ID: 18444912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Skin Rejection Grading System for Vascularized Composite Allotransplantation in a Preclinical Large Animal Model.
    Etra JW; Grzelak MJ; Fidder SAJ; Kolegraff K; Bonawitz S; Shores J; Oh B; Cooney DS; Beck SE; Brandacher G
    Transplantation; 2019 Jul; 103(7):1385-1391. PubMed ID: 31241555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosa and Rejection in Facial Vascularized Composite Allotransplantation: A Systematic Review.
    Kauke M; Safi AF; Zhegibe A; Haug V; Kollar B; Nelms L; Palmer WJ; Tchiloemba B; Lian CG; Murphy GF; Pomahac B
    Transplantation; 2020 Dec; 104(12):2616-2624. PubMed ID: 32053572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Banff 97 working classification of renal allograft pathology.
    Racusen LC; Solez K; Colvin RB; Bonsib SM; Castro MC; Cavallo T; Croker BP; Demetris AJ; Drachenberg CB; Fogo AB; Furness P; Gaber LW; Gibson IW; Glotz D; Goldberg JC; Grande J; Halloran PF; Hansen HE; Hartley B; Hayry PJ; Hill CM; Hoffman EO; Hunsicker LG; Lindblad AS; Yamaguchi Y
    Kidney Int; 1999 Feb; 55(2):713-23. PubMed ID: 9987096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts.
    Kanitakis J; Karayannopoulou G; Lanzetta M; Petruzzo P
    Transpl Int; 2014 Nov; 27(11):e118-23. PubMed ID: 25041139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
    Loupy A; Haas M; Solez K; Racusen L; Glotz D; Seron D; Nankivell BJ; Colvin RB; Afrouzian M; Akalin E; Alachkar N; Bagnasco S; Becker JU; Cornell L; Drachenberg C; Dragun D; de Kort H; Gibson IW; Kraus ES; Lefaucheur C; Legendre C; Liapis H; Muthukumar T; Nickeleit V; Orandi B; Park W; Rabant M; Randhawa P; Reed EF; Roufosse C; Seshan SV; Sis B; Singh HK; Schinstock C; Tambur A; Zeevi A; Mengel M
    Am J Transplant; 2017 Jan; 17(1):28-41. PubMed ID: 27862883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytic Vasculitis Associated With Mild Rejection in a Vascularized Composite Allograft Recipient: A Clinicopathological Study.
    Roy SF; Krishnan V; Trinh VQ; Collette S; Dufresne SF; Borsuk DE; Désy D
    Transplantation; 2020 Jul; 104(7):e208-e213. PubMed ID: 32235257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally and Non-invasive Approaches to Rejection Identification in Vascularized Composite Allotransplantation.
    Stead TS; Brydges HT; Laspro M; Onuh OC; Chaya BF; Rabbani PS; Lu CP; Ceradini DJ; Gelb BE; Rodriguez ED
    Transplant Rev (Orlando); 2023 Dec; 37(4):100790. PubMed ID: 37625211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.
    Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ
    Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
    Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
    J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP3 Is a Non-invasive Biomarker of Rejection in Skin-Bearing Vascularized Composite Allotransplantation: A Multicenter Validation Study.
    Kollar B; Uffing A; Borges TJ; Shubin AV; Aoyama BT; Dagot C; Haug V; Kauke M; Safi AF; Talbot SG; Morelon E; Dakpe S; Pomahac B; Riella LV
    Front Immunol; 2019; 10():2771. PubMed ID: 31849957
    [No Abstract]   [Full Text] [Related]  

  • 17. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
    Haas M; Sis B; Racusen LC; Solez K; Glotz D; Colvin RB; Castro MC; David DS; David-Neto E; Bagnasco SM; Cendales LC; Cornell LD; Demetris AJ; Drachenberg CB; Farver CF; Farris AB; Gibson IW; Kraus E; Liapis H; Loupy A; Nickeleit V; Randhawa P; Rodriguez ER; Rush D; Smith RN; Tan CD; Wallace WD; Mengel M;
    Am J Transplant; 2014 Feb; 14(2):272-83. PubMed ID: 24472190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robustness Testing of Mesenchymal Stem Cell Monotherapy Following Vascularized Composite Allotransplantation.
    Steinberger Z; Xu H; Kazmers NH; Chen CD; Caron RJ; Qin L; Zhang Y; Levin LS
    J Reconstr Microsurg; 2020 Jul; 36(6):397-402. PubMed ID: 32040964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologies of oral and sinonasal mucosa following facial vascularized composite allotransplantation.
    Kauke-Navarro M; Tchiloemba B; Haug V; Kollar B; Diehm Y; Safi AF; Treister NS; Annino DJ; Marty FM; Lian CG; Murphy GF; Pomahac B
    J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1562-1571. PubMed ID: 33376080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascularized composite allotransplants as a mechanistic model for allograft rejection - an experimental study.
    Moris D; Wang J; Selim MA; Song M; Stempora L; Parker W; Kirk AD; Cendales LC
    Transpl Int; 2021 Mar; 34(3):572-584. PubMed ID: 33453073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.